© 2021 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.

Advertisement

#EASL 2015
Click Here for More Conferences
Click Here for EASL.eu
An Introduction to Hepatitis

Conferences

Generic Hepatitis C Drugs Appear Highly Effective

Generic versions of major hepatitis C drugs are apparently very effective.

Treating Hep C Halves New Cases Among UK Gay Men

Scaling up treatment of hepatitis C among gay and bisexual men in the United Kingdom could in half the number of new cases among that populati...

Losing Weight Is Linked to Improvement in NASH

People with non-alcoholic steatohepatitis who lose significant body weight are likely to experience improvements in their disease condition.

NASH Increases Risk of Death by 50% Over NAFLD

Non-alcoholic steatohepatitis (NASH) is associated with a 50 percent greater risk of death than non-alcoholic fatty liver disease (NAFLD).

Diabetes Drug Appears to Clear NASH in Some Cases

The diabetes drug Victoza (liraglutide) has apparently eliminated NASH in a significant proportion of those treated in a recent trial.

MUST read

Hepatitis C: The Basics
Hepatitis B: The Basics
Hepatitis A: The Basics

Fatty Liver Disease Rising as Liver Cancer Cause

With a quarter of Americans living with the condition, fatty liver disease is increasingly a cause of liver cancer.

Early Study of Hepatitis B Immune Therapy Raises Cure Hopes

A new immune therapy targeting hepatitis B has shown promise in an animal study.

Screening for Hep C is Vital to Catch Progressing Liver Damage

Knowing your hepatitis C status has no apparent effect on the likelihood of your developing advanced liver fibrosis.

New Treatment Could Fight Liver Cancer

Researchers have identified a new therapy that could help treat liver cancer in a certain subset of people with the disease.

Hep C Treatment Can Help Those With Advanced Liver Disease

Various combinations of Sovaldi, Olysio and ribavirin can cure hepatitis C among those with decompensated cirrhosis.

Hot topics

Forums: Support and discussion
Blogs: The community speaks

Diabetes Drug May Help Treat Non-Alcoholic Liver Disease

An investigational anti-diabetes drug may be an option for treating NASH and NAFLD.

Daclatasvir Plus Sovaldi Shows Promise Curing Hard-to-Treat Hep C

Daclatasvir and Sovaldi, with or without ribavirin, seem likely to lead to relatively good cure rates among people with genotype 3 of hepatiti...

Cure for Almost All Hep C-Positive Liver Transplantees

Daclatasvir and Sovaldi, with or without ribavirin, offer near-perfect hepatitis C cure rates among those who have received a liver transplant...

Hepatitis C Is a Risk Factor for Heart Disease

People with hepatitis C are at increased risk of cardiovascular disease.

One in Five People With Hep C Likely Have Advanced Liver Disease

A significant proportion of people with undiagnosed hepatitis C likely have advanced liver disease and are in relatively urgent need of treatm...
Advertisement
Science News
Newsfeed
Features
Ask Hep